About
b-rayZ is a Swiss healthcare technology company founded in 2019 as a spin-off from the University Hospital of Zurich. The company specializes in advanced AI solutions for breast imaging, aiming to empower radiologists, technicians, and clinical managers. Their focus is on optimizing workflows, automating non-critical tasks, ensuring quality assurance, and providing diagnostic assistance in breast cancer detection. The company offers a comprehensive AI platform that supports the entire breast imaging diagnostic journey. Key products include the b-box, an innovative breast imaging system with CE certification, and b-diagnose, a diagnostic tool that aids in cancer diagnosis and breast density assessment. Their DANAI technology is recognized as the world’s first AI medical technology for breast cancer diagnostics. b-rayZ’s solutions are designed to integrate seamlessly with existing IT infrastructures, enhancing efficiency and reducing the risk of misdiagnosis. With a vision to transform breast cancer care, b-rayZ combines AI innovation with medical expertise to improve early detection and streamline clinical workflows. The company has achieved significant milestones, including CE certifications and market entry in Norway.
Technologies
Keywords
Company Information
-
Employees 16
-
Founded 2019
-
Total Funding $4123360
Location
21 Wagistrasse, Schlieren, Zurich, Switzerland, 8952
